SOLVE(D) | An IPG Health Company’s Post

What are the 𝐤𝐞𝐲 𝐩𝐡𝐚𝐫𝐦𝐚 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐧𝐞𝐰𝐬 & 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 of the first semester of 2024? A few weeks ago, I stumbled upon this amazing work by Gary Monk on LinkedIn, showcasing the main digital pharma collaborations in a single image. Brilliant! 👏 But let's be honest, this is just the tip of the iceberg. 🌐 What other groundbreaking partnerships are out there? 💡 Want to be part of the next collaboration map? 🤝 Let's inspire more collaborations together! 🚀 #digitalpharma #pharmaindustry #collaboration #innovation #healthcare

"Digital and in-person interactions should be personalized to truly meet the needs of the individual." - Chase Feiger, M.D. on redefining pharma marketing 🎙️: Listen to Chase speak on the need for personalized engagement on the Modern Clinician webinar from last week, hosted by RoseRx

Pulse Edge specializes in guiding life science companies through the complex path to market access. From early strategic planning and market analysis to value proposition development and launch readiness, we support strategic decision-making to ensure that value-adding therapies reach patients. Our expertise spans commercial strategy, pipeline planning, market valuation, and launch excellence. Our commitment is to support your growth by delivering successful outcomes. Interested in how we could help you navigate the road to revenues? Let's connect. #MarketAccess #PharmaStrategy #HealthInnovation 

Looking forward to Eryn Veronesi Atypical Digital Life Sciences, and Magnolia talk about Biopharma in the digital era today at 1 pm ET! Learn about the latest trends and insights in the industry. #biopharma #digital

The dynamic evolution of media has become integral in life sciences marketing, allowing distinct opportunities to manifest in most lucrative ways possible. In The Next Marketing With HJ series, as I exchanged thoughts with Richard Springham, Managing Director, Initiative, I realized why navigating strict guidelines demands innovation to employ diverse media platforms and most importantly disseminate accurate information to both – HCPs & Patients. Embracing evolving media roles not only communicates scientific advancements effectively but also ensures ethical dissemination, empowering the life sciences sector to connect authentically while adhering to regulatory standards! Well, that’s what my learning was from the episode! What's yours? https://lnkd.in/gh2DBEg8 #evolvingmedia #richardspringham #thenextmarketingwithhj #season1 #learningwithrichard #takeaway #media #regulatedmarkets

In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:

In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:

With so much change in the social media landscape, where should pharma focus? Head over to Pharma in Focus to hear more from Frankly Pharma founder, Bridget Ash on the trends to watch in 2024 > https://lnkd.in/ghKcitui #pharmamarketing #socialmedia #socialtrends #healthcarecommunications

In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media:

In a recent KPMG survey of deal-maker preference across healthcare and life sciences, late-stage assets garnered 70% of the vote, versus 55% for early-stage, highly innovative assets and 45% for agents at the commercial stage. Read more in Medical Marketing and Media: